J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative
This week in Phispers, we bring you news on J&J’s Invokana, a drug that reduces heart risk
Phispers: Another Heparin scandal in China, GSK may have a new CEO, Female libido pill problems
Pharmaceutical Whispers (Phispers) this week cover another major heparin scandal emanating from
Novartis’ plant shut down creates urgency to find alternatives to Chinese APIs
With Novartis shutting two plants in Germany and one in India by 2016-end, the global reliance on Ch